British American Tobacco PLC vs 10X Genomics Inc — how do they compare? British American Tobacco PLC trades at $56.94 (market cap $122.36B), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: British American Tobacco PLC is far larger — about 16.1× 10X Genomics Inc's market cap, and British American Tobacco PLC pays a 5.88% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| BTI | TXG | |
|---|---|---|
Market Cap | $122.36B | $7.61B |
Sector | Consumer Staples | Health |
52-Week High | $66.70 | $58.57 |
52-Week Low | $50.39 | $11.34 |
Enterprise Value | $166.31B | $7.14B |
Dividend Yield | 5.88% | — |
Trailing returns across standard periods
Latest headlines on both assets
Following the acquisition of Reynolds American, British American Tobacco is neck-and-neck with Philip Morris International to be the largest listed global tobacco company--slightly larger than PMI on net revenue, but slightly smaller on total tobacco volume. British American's Global Drive Brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans, and it also owns Newport and Camel in the U.S. The firm also sells vapor e-cigarettes, including its Vype brand, heated tobacco, with Glo, as well as roll- your-own and smokeless tobacco products. The company holds 31% of ITC Limited, the leading Indian cigarette-maker.
Read more on BTI →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →